Skip to main content
. 2018 Nov 15;30(1):7–16. doi: 10.1111/pai.12990

Table 3.

Considerations for omalizumab use in the pediatric asthma population

Reduction of viral‐induced exacerbations
Potential to treat multi‐morbidities, including allergic rhinitis and food allergy
Limitations of the dosing table
Potential for home administration
Good safety profile